Anzeige
Mehr »
Login
Mittwoch, 08.12.2021 Börsentäglich über 12.000 News von 671 internationalen Medien
Unfassbare News! 90 Tonnen "Süßkram" für Yumy Bear Goods!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 886413 ISIN: US0383361039 Ticker-Symbol: AGT 
Tradegate
08.12.21
19:42 Uhr
106,30 Euro
-0,50
-0,47 %
1-Jahres-Chart
APTARGROUP INC Chart 1 Jahr
5-Tage-Chart
APTARGROUP INC 5-Tage-Chart
RealtimeGeldBriefZeit
106,10106,3019:54
106,20106,3019:55
Actusnews Wire
491 Leser
Artikel bewerten:
(2)

VOLUNTIS: Voluntis announces the success of the Tender Offer initiated by the company AptarGroup allowing the implementation of mandatory squeeze-out

Cambridge (USA), Paris (France), October 18, 2021 - Voluntis (Euronext Growth Paris, Ticker: ALVTX - ISIN: FR0004183960 - "the Company"), a leader in the field of digital therapeutics, announces the successful completion of the Simplified Tender Offer ("the Offer") initiated by AptarGroup, Inc. ("Aptar" - NYSE: ATR) to acquire the shares of Voluntis. As a result of the Offer, Aptar has exceeded the threshold of 90% of the share capital and theoretical voting rights of Voluntis and will therefore file a request with the AMF for the implementation of a squeeze-out of the Voluntis shares not tendered to the Offer followed by the delisting of the Company's shares from Euronext Growth. The notice of the result of the Offer was published today by the French Markets Authority (AMF).

Result of the Offer

At the end of this Offer, which closed on October 15, 2021, a number of 1,967,612 Voluntis shares were tendered to the Offer, representing 21.64% of the Company's share capital. Thus, Aptar acquired 87.58% of the shares targeted by the Offer and therefore holds 8,774,907 Voluntis shares representing 96.53% of the share capital and at least 95.53% of the theoretical voting rights of Voluntis. As a result, the Company's capital is now distributed as follows:

Number of shares% of capitalNumber of theoretical voting rights% of theoretical voting rights
Aptargroup Holding SAS8,774,90796.53%8,774,90795.53%
Public278,9573.07%374,2704.07%
Treasury shares36,6490.40%36,6490.40%
Total9,090,513100%9,196,782100%

Mandatory squeeze-out of Voluntis shares not tendered to the Offer

At the end of the Offer, Aptar crossed the threshold of 90% of the share capital and theoretical voting rights of Voluntis, which allows the group to file with the AMF a request for the implementation of a mandatory squeeze-out concerning all the Voluntis shares not tendered to the Offer (with the exception of the treasury shares held by Voluntis and the Kreos warrants), as provided for in prospectus and the note in response relating to the Offer, and in accordance with the conditions of article L. 433-4, II of the French Monetary and Financial Code and articles 237-1 et seq. of the AMF's General Regulations.

In this context, the shares that would not have been tendered to the Offer would be transferred to Aptar in consideration for a cash compensation equal to the Offer price per share (i.e. 8.70 euros per Voluntis share) net of all expenses. The listing of the Voluntis shares has been suspended pending the implementation of the squeeze-out which will take place in the next few days and will be followed by the delisting of the Voluntis shares from Euronext Growth.

Aptar's prospectus and Voluntis' note in response, which received AMF approval on September 28, 2021 under numbers 21-419 and 21-420, respectively, as well as the documents relating to the other information of the two companies, are available on the websites of the AMF (www.amf-france.org), of Aptar (www.aptar.com) and of Voluntis (https://www.voluntis.com/investors/tender-offer/). These documents can be obtained free of charge from the head offices of both companies.

# # #

About Voluntis

Voluntis creates digital therapeutics that empower people with chronic conditions to self-manage their treatment every day, thus improving real-world outcomes. Voluntis' solutions, combining mobile and web apps, use clinical algorithms to deliver personalized recommendations to patients and their care teams. For example, these recommendations are used to adjust treatment dosage, manage side effects or monitor symptoms. Leveraging its Theraxium technology platform, Voluntis has designed and operates multiple digital therapeutics, especially in oncology and diabetes. Voluntis has long-standing partnerships with leading life science companies. Based in Cambridge, MA, and Paris, France, Voluntis is a founding member of the Digital Therapeutics Alliance.

For more information, please visit: www.voluntis.com

Contacts

ACTUS
Media Relations
Vivien Ferran

vferran@actus.fr
+33 (0)1 53 67 36 34
ACTUS
Investor Relations
Jérôme Fabreguettes-Leib

voluntis@actus.fr
+33 (0)1 53 67 36 78
Voluntis
Chief Financial Officer
Guillaume Floch

investisseurs@voluntis.com
+33 (0)1 41 38 39 20
------------------------
This publication embed "Actusnews SECURITY MASTER".
- SECURITY MASTER Key: ymmalplnYmrFxpucZJZsb5KXaWtoxGGVbmSemZRql5udZ5+RlJqXnJqYZnBimmln
- Check this key: https://www.security-master-key.com.
------------------------
Full and original release in PDF format:
https://www.actusnews.com/documents_communiques/ACTUS-0-71541-voluntis_cp_resultat_opa_vdef_en.pdf

© Copyright Actusnews Wire
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
APTARGROUP-Aktie komplett kostenlos handeln - auf Smartbroker.de
© 2021 Actusnews Wire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.